4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-22-026346
Options or other derivatives
- President and CEO acquired 604,308 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Brady Todd C President and CEO | 2022-07-15 | Grant or award · Bonus Units | +604,308 | 604,308 | D | ||
Loading xslF345X03/doc4.xml…